Cohera Medical, Inc.® Announces $50 Million in New Financing
October 22, 2015
Cohera Medical has made significant strides in the last year, achieving
“In clinical trials, surgeons were able to eliminate the need for
post-surgical drains by using TissuGlu, reducing the need for invasive
treatments for their abdominoplasty patients, and improving the patient
recovery process. The Premarket Approval (PMA) supports the safety and
effectiveness of TissuGlu as an alternative to the use of closed suction
drains,” said
As part of the transaction,
Cohera Medical recently received PMA approval for TissuGlu Surgical Adhesive indicated for the approximation of tissue planes in abdominoplasty procedures. Currently, most patients who undergo abdominoplasty procedures and other flap procedures require the insertion of drains to remove fluids that accumulate under the skin at the surgical site. TissuGlu adheres the tissue flap created during the procedure to the underlying tissue, helping to reduce the fluid that can accumulate in the space. In clinical trials, surgeons were able to eliminate the need for post-surgical drains in most abdominoplasty cases by using TissuGlu, reducing the need for invasive treatments for their abdominoplasty patients and improving the patients’ ability to return to normal activities.
Cohera’s product pipeline also includes Sylys, a resorbable synthetic
sealant designed to help reduce anastomotic leakage in gastrointestinal
procedures by providing additional support to the anastomosis during the
first few days of healing, when the development of leaks is most likely
to occur. Anastomotic leakage, which occurs in three to twenty-three
percent of patients undergoing gastrointestinal surgery, is considered
to be the most serious surgical complication encountered. The
For KKR, the investment is part of the firm’s health care growth equity
strategy, which is focused on high-growth companies for which KKR can be
a unique partner in helping reach scale. KKR is funding the investment
primarily from the balance sheet of
About Cohera Medical
About KKR
KKR is a leading global investment firm that manages investments across
multiple asset classes including private equity, energy, infrastructure,
real estate, credit, and hedge funds. KKR aims to generate attractive
investment returns by following a patient and disciplined investment
approach, employing world-class people, and driving growth and value
creation at the asset level. KKR invests its own capital alongside its
partners’ capital and brings opportunities to others through its capital
markets business. References to KKR’s investments may include the
activities of its sponsored funds. For additional information about
View source version on businesswire.com: http://www.businesswire.com/news/home/20151022005456/en/
SalesForce4Hire
aharris@salesforce4hire.com
Source:
Back to Press Releases
Media Contacts
Americas
Miles Radcliffe-Trenner
Telephone: +1 (212) 750-8300
Email: media@kkr.com
Investor Relations
Craig Larson
Telephone: +1 (877) 610-4910
Outside US: +1 (212) 230-9410
Facsimile: +1 (212) 750-0003
Email: Investor-Relations@kkr.com